Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban.
Authors : Morell Jason J; Sullivan Bridgette B; Khalabuda Marina M; McBride Brian F BF;
Affiliations : Loyola University Medical Center.
Journal : N/A (2010)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...